(Q35796578)

10 August 2017

1 reference

title

Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor (English)

1 reference

10 August 2017

1 reference

Leriche L

1

1 reference

10 August 2017

Diaz J

series ordinal

2

1 reference

10 August 2017

Sokoloff P

series ordinal

3

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

published in

Neurotoxicity Research

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

63-71

1 reference

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03033298

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033298

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033298

Dopamine receptor gene expression in the human medial temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033298

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033298

Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.

21 January 2018

1 reference

12 December 2020

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

1 reference

12 December 2020

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.

1 reference

12 December 2020

Effect of Phencyclidine in Chronic Schizophrenics

1 reference

12 December 2020

Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues

1 reference

12 December 2020

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

1 reference

12 December 2020

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

1 reference

12 December 2020

Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors

1 reference

12 December 2020

Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach.

1 reference

12 December 2020

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

1 reference

12 December 2020

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment

1 reference

12 December 2020

Basal forebrain in the context of schizophrenia

1 reference

12 December 2020

Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

1 reference

12 December 2020

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

12 December 2020

Clinical studies with dopamine-receptor stimulants

1 reference

12 December 2020

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

1 reference

12 December 2020

Functional role of the nigro-neostriatal dopamine neurons

1 reference

12 December 2020

D2-family receptor distribution in human postmortem tissue: an autoradiographic study

1 reference

12 December 2020

Schizophrenia: the fundamental questions

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

12 December 2020

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies

1 reference

12 December 2020

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

1 reference

12 December 2020

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

1 reference

12 December 2020

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1 reference

12 December 2020

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

1 reference

12 December 2020

Half a century of antipsychotics and still a central role for dopamine D2 receptors

1 reference

12 December 2020

Receptor Adaptations to Centrally Acting Drugs

1 reference

12 December 2020

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

12 December 2020

Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP)

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens

1 reference

12 December 2020

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

1 reference

12 December 2020

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

1 reference

12 December 2020

1 reference

12 December 2020

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

1 reference

12 December 2020

Distinct functions of the two isoforms of dopamine D2 receptors

1 reference

12 December 2020

Amphetamine psychosis: behavioral and biochemical aspects

1 reference

12 December 2020

Receptor mechanisms mediating clozapine-inducedc-fos expression in the forebrain

1 reference

12 December 2020

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade

1 reference

12 December 2020

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

12 December 2020

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

12 December 2020

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

1 reference

12 December 2020

D3 dopamine receptor mRNA is widely expressed in the human brain

1 reference

12 December 2020

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

1 reference

12 December 2020

Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography

1 reference

12 December 2020

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

1 reference

12 December 2020

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Novel dopamine receptor subtypes as targets for antipsychotic drugs

1 reference

12 December 2020

Dopamine receptors: from structure to function

1 reference

12 December 2020

PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs

1 reference

12 December 2020

Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors

1 reference

12 December 2020

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

1 reference

12 December 2020

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

12 December 2020

Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents

1 reference

12 December 2020

Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats

1 reference

12 December 2020

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

1 reference

12 December 2020

The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain

1 reference

12 December 2020

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system

1 reference

12 December 2020

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

1 reference

12 December 2020

Iloperidone binding to human and rat dopamine and 5-HT receptors

1 reference

12 December 2020

[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.

1 reference

12 December 2020

Lack of a role for the D3 receptor in clozapine induction of c-fos demonstrated in D3 dopamine receptor-deficient mice

1 reference

12 December 2020

Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033298

1 reference

10 August 2017

1 reference